As a result, we hypothesize that uPAR-PET could potentially serve as a prognostic marker of tumor aggressiveness in gliomas and that uPAR-PET positive gliomas may be future candidates for uPAR-targeted PRRT. This evidence concerns the gene PLAUR and central nervous system cancer.